The Effect of MK0633 in Patients With Chronic Asthma (0633-007)

• Status: Terminated
• Trial end date: 2009-06-01
• Target enrollment: 0
• Participant gender: All

Summary

A clinical study to evaluate the efficacy and safety of MK0633 in adult patients with chronic asthma.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.

Criteria

Inclusion Criteria:

• Documented clinical history of symptoms of chronic asthma, including dyspnea, wheezing, chest tightness, cough, and/or sputum production

• Males and females 18-70 years of age

Exclusion Criteria:

• History of kidney or chronic liver disease

• Recent history of heart problems within the past 3 months

• Evidence of another clinically significant, active lung disorder such as bronchiectasis or COPD